Results 161 to 170 of about 284,262 (205)
Some of the next articles are maybe not open access.
Fibrinogen, Fibrinogen Degradation Products and Erythrocyte Flexibility
Thrombosis and Haemostasis, 1977SummaryAn investigation has been made of the effect of fibrinogen concentration and fibrinogen degradation products on the flexibility of erythrocytes. The measurements were made using the blood of 2 donors, one representative of the normal population, the other representative of the 1.
M W, Rampling, J A, Sirs
openaire +2 more sources
Fibrinogen marburg a new genetic variant of fibrinogen
Blut, 1977A new case of congenital dysfibrinogenemia has been discovered in a 20 year old woman, who suffered from a severe postpartal hemorrhage after the delivery of her first child, followed by episodes of thrombosis. Coagulation studies reveal a prolongation of thrombin time, reptilase time was immeasurable.
G, Fuchs, R, Egbring, K, Havemann
openaire +2 more sources
European Heart Journal, 1995
As evidence accumulates to implicate fibrinogen as a risk factor for cardiovascular disease (CVD) it becomes important to characterize the levels and correlates of fibrinogen in diverse populations. Knowledge of the correlates of fibrinogen may help researchers to disentangle the independent contribution of elevated fibrinogen concentrations to CVD ...
openaire +2 more sources
As evidence accumulates to implicate fibrinogen as a risk factor for cardiovascular disease (CVD) it becomes important to characterize the levels and correlates of fibrinogen in diverse populations. Knowledge of the correlates of fibrinogen may help researchers to disentangle the independent contribution of elevated fibrinogen concentrations to CVD ...
openaire +2 more sources
Fibrinogen ‘Haifa’ – A New Fibrinogen Variant
Pathophysiology of Haemostasis and Thrombosis, 1983A 30-year-old female presenting with arterial occlusions of the lower limbs was discovered to have a markedly abnormal thrombin time and reptilase time. Further investigations revealed the presence of a qualitatively abnormal fibrinogen. Two other family members who were completely asymptomatic had similar defects.
J.G. Brook +4 more
openaire +1 more source
Annual Review of Biochemistry, 1975
Fibrinogen is a soluble plasma protein that is converted to polymeric fibrin in response to damage to the vascular system. The clotting process is initiated when platelets aggregate at the wound site. Their disruption releases biologically active amines and a proteolytic cascade follows which culminates in the conversion of fibrinogen to fibrin.
openaire +3 more sources
Fibrinogen is a soluble plasma protein that is converted to polymeric fibrin in response to damage to the vascular system. The clotting process is initiated when platelets aggregate at the wound site. Their disruption releases biologically active amines and a proteolytic cascade follows which culminates in the conversion of fibrinogen to fibrin.
openaire +3 more sources
Radioimmunoassay of fibrinopeptide A — Immunoreactivity of fibrinogen and fibrinogen fragments
Thrombosis Research, 1980Abstract Anti-fibrinopeptide A antisera with different immunochemical specificities for human fibrinopeptide A (FPA), when it is part of fibrinogen or fibrinogen fragments, were used in the radioimmunoassay of FPA to demonstrate different susceptibility of native and purified molecules to degradation.
openaire +2 more sources
[Fibrinogen "Hannover", a further abnormal fibrinogen].
Blut, 1977Another abnormal fibrinogen--"fibrinogen Hannover"--is reported. As known from most dysfibrinogenemias the clottability is poor, while immunologic test, heat precipitating test and the staphylococcal clumping test give normal fibrinogen concentrations. The clotting time when using thrombin or thrombin like enzymes is prolonged, it can be corrected with
M, Barthels, G, Sandvoss
openaire +1 more source